This document is an excerpt from the EUR-Lex website
Document C2004/228/95
Order of the Court of First Instance of 2 June 2004 in Case T-123/03 Pfizer Ltd v Commission of the European Communities (Medicinal products for human use — Initiation, under Article 30 of Directive 2001/83/EC, of the procedure under Article 32 of that directive — Application for annulment — Measure against which an action may be brought — Preparatory measure — Inadmissible)
Order of the Court of First Instance of 2 June 2004 in Case T-123/03 Pfizer Ltd v Commission of the European Communities (Medicinal products for human use — Initiation, under Article 30 of Directive 2001/83/EC, of the procedure under Article 32 of that directive — Application for annulment — Measure against which an action may be brought — Preparatory measure — Inadmissible)
Order of the Court of First Instance of 2 June 2004 in Case T-123/03 Pfizer Ltd v Commission of the European Communities (Medicinal products for human use — Initiation, under Article 30 of Directive 2001/83/EC, of the procedure under Article 32 of that directive — Application for annulment — Measure against which an action may be brought — Preparatory measure — Inadmissible)
JO C 228, 11.9.2004, p. 42–42
(ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
|
11.9.2004 |
EN |
Official Journal of the European Union |
C 228/42 |
ORDER OF THE COURT OF FIRST INSTANCE
of 2 June 2004
in Case T-123/03 Pfizer Ltd v Commission of the European Communities (1)
(Medicinal products for human use - Initiation, under Article 30 of Directive 2001/83/EC, of the procedure under Article 32 of that directive - Application for annulment - Measure against which an action may be brought - Preparatory measure - Inadmissible)
(2004/C 228/95)
Language of the case: English
In Case T-123/03: Pfizer Ltd, established in Sandwich, Kent (United Kingdom), represented by D. Anderson QC, K. Bacon, Barrister, I. Dodds-Smith and T. Fox, Solicitors, against Commission of the European Communities (Agents: H. Støvlbaek and X. Lewis, acting as Agents, with an address for service in Luxembourg ) — application for the annulment of the Commission Decision of 6 January 2003 initiating a referral to the European Agency for the Evaluation of Medicinal Products (EMEA) in relation to Lopid under Article 30 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67) — the Court of First Instance (Fourth Chamber), composed of: H. Legal, President, V. Tilli and M. Vilaras, Judges; H. Jung, Registrar, has made an order on 2 June 2004, the operative part of which is as follows:
|
1. |
The application is dismissed as inadmissible. |
|
2. |
The applicant shall pay the costs. |